# Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks)

> **NCT02958488** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 50 (actual)

## Conditions studied

- Respiratory Distress Syndrom
- High Flow Nasal Cannula

## Interventions

- **DEVICE:** High Flow Nasal Cannula

## Key facts

- **NCT ID:** NCT02958488
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-16
- **Primary completion:** 2019-07
- **Final completion:** 2020-08-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958488, "Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02958488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*